UBS Initiates Coverage On Astera Labs with Neutral Rating, Announces Price Target of $180

Benzinga Newsdesk www.benzinga.com Neutral 78.9%

Neg 0% Neu 78.9% Pos 0%

UBS analyst Natalia Winkler initiates coverage on Astera Labs (NASDAQ:ALAB) with a Neutral rating and announces Price Target of $180.